<p>Rayvow is a medicine used to treat migraine with or without aura (unusual visual or other sensory experiences) in adults.</p><p>Rayvow contains the active substance lasmiditan.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>RAYVOW is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.</p> </div>
Therapeutic Area (MeSH)
ATC Code
N02CC08
ATC Item
N/A
Pharmacotherapeutic Group
Analgesics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| lasmiditan succinate | N/A | lasmiditan succinate |
EMA Name
Rayvow
Medicine Name
Rayvow
Aliases
N/ANo risk management plan link.
